SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous celt head and neck cancer (SCHNC). Evaluation of the early results and toxicity

Journal Title: Otolaryngologia Polska - Year 2011, Vol 65, Issue 5

Abstract

SUMMARY Concomitant radiochemotherapy become the treatment of choice for lo-cally advanced SCHNC. This strategy of treatment has a limitation, which is an acute and late toxicity. The IMRT technique provides the possibility of better sparing of healthy tissue. Radiobiological and clinical data also suggest that accelerated fractionation and higher dose per fraction given in GTV may produce better locoregional control. Therefore it might be expected that concomitant chemotherapy and SIB-IMRT radiotherapy could increase locoregional control and reduce acute and late radiation reactions. The evaluation of early results and toxicity of this treatment modality is presented. Aim of study: The evaluation of the early results and toxicity of SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous celt head and neck cancer (SCHNC). Methods: SIB-IMRT technique was applied. The boost volume was limited to the GTV + 3 mm margin (macroscopic tumor extension was defined on the basis of CT and/or MRI examinations). Dose per fraction given to this volume was 2.25 Gy up to 67.5 Gy of total dose. The PTV-CTV + 3 mm — was defined as an area of increased risk of microscopic spread. Dose per fraction given to this volume was 2 Gy up to 60 Gy. The PTV1-ETV+ 3mm (electively irradiated volume) received dose per fraction —1.8 Gy up to 54-56 Gy. Overall treatment time was 6 weeks (5 fractions per week, 30 fractions). Concomitant chemotherapy consisted of cisplatin in daily dose100mg/m2 given two times during irradiation (1 and 22 day of treatment). The evalu-ation of early tolerance was performed once weekly during the treatment than during the follow up every 2 months. The early reactions were scored according to the EORTC/RTOG scale. Material: Between June 2006 and December 2009 99 patients diagnosed with III and IV clinical stage of SCHNC were treated with this method. 65 patients were diagnosed with oropharyngeal cancer, 18 with Iaryngeal cancer and 16 with hypopharyngeal cancer. PEG was performed at 65 patients before treatment for better alimentation during radiochemotherapy. Results: No severe life risking complications were observed a no concequen-tional late effects were observed. Extended mucositis grade III according RTOG/EORTC scale were observed only in boost region in 80% patients just after treatment was completed. In 2 patients ulceration were observed in tumour side which have healed up spontaneously within two months after treatment. 55% patients were suffering for III xerostomia and 41% for mid-dle after the treatment.

Authors and Affiliations

Dorota Kiprian, Andrzej Jarząbski, Beata Pawłowska, Wojciech Michalski

Keywords

Related Articles

The otologic manifestation of Wegener's granulomatosis — reuiew of contemporary achieuements in diagnostics and treatment

Objective: Wegener granulomatosis (WG) presents nasal, laryngeal and otologic symptoms as an initial signs of the disease and finally can affect the ENT region in 3/4 patients. The authors want to analyze 7 cases of WG w...

Śluzowiak zatok sitowych penetrujący do oczodołu i przedniego dołu czaszki – opis przypadku

Paranasal sinus mucocele is the cystic formation lined by inflammatory changed mucoperiosteum. This is slow-growing pathology with a tendency to bone erosion. The symptoms are dependent on the direction of the penetratio...

Czynniki ryzyka nawrotu gruczolaka wielopostaciowego

Gruczolak wielopostaciowy jest najczęstszym nowotworem łagodnym gruczołów ślinowych. Cechuje go skłonność do nawrotów, która uwarunkowana jest cechami biologicznymi guza, jak również sposobem jego leczenia. Nawroty choro...

Comparison of different deafening strategies based on ototoxic drugs on mouse animals model

SUMMARY Aim of the study: To compare safety, reliability and usefulness of two deafening protocols on animal mouse model, based on aminoglycosides exposure Material and method: Adults mice, Bulb/C, deafened with kanamyci...

Download PDF file
  • EP ID EP52378
  • DOI -
  • Views 78
  • Downloads 0

How To Cite

Dorota Kiprian, Andrzej Jarząbski, Beata Pawłowska, Wojciech Michalski (2011). SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous celt head and neck cancer (SCHNC). Evaluation of the early results and toxicity. Otolaryngologia Polska, 65(5), -. https://europub.co.uk./articles/-A-52378